Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test on IUI day may reveal pregnancy clues

NCT ID NCT07038616

Knowledge-focused Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 158 women having intrauterine insemination (IUI) to see if progesterone levels on the day of insemination are linked to pregnancy rates. IUI is a simpler, cheaper fertility treatment than IVF, but success rates are low. Researchers measured progesterone and other hormones in routine blood tests. The goal is to find a way to better time insemination and improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If a link is found, this could help doctors time insemination better and improve IUI success rates without extra drugs.
What could go wrong
This is a small, completed observational study, not a treatment trial. It only looks for a correlation, so it won't prove what works best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

158 people

The number who actually took part.

Started

Oct 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of single women or couples, heterosexual or homosexual, undergoing insemination at a medically assisted procreation (MAP) center. Participants are aged between 18 and 43 years old. They have an indication for intrauterine insemination (IUI) in accordance with the Recommendations for Good Practices in Assisted Reproductive Medicine (RBP). . Only those who have had a blood as part of routine care on the day of insemination, will be included in the study.

Ages

18 to 43 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Single women or couples, heterosexual or homosexual, undergoing insemination at the medically assisted procreation.center * Aged 18 to 43 * Any indication for IUI in compliance with the Recommendations for Good Practices in MPA (RBP) * Blood test on the day of insemination with estradiol, progesterone, LH and hCG measured as part of routine care Exclusion Criteria: -Opposition of patients to data collection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infertility are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infertility

Contacts and locations

Locations

  • Chi Creteil

    Créteil, CHI Créteil, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.